Patents
RBC scientists are singularly focused on the development of new and novel processes for the manufacture of active pharmaceutical ingredients and high purity excipients. We manufacture a number of high potency active ingredients using RBC’s proprietary patented processes. RBC scientists have also developed novel technology to address drug discovery and development problems in anticoagulant and anticancer therapeutics.
We devise new, non-infringing processes for the manufacture of active ingredients used in generic pharmaceuticals developed by our clients. We protect the developed manufacturing processes with intellectual property patent filings which allow RBC the freedom to operate and provide our clients security of supply for their APIs.
Issued patents:
| Patent Number | Title | Issued |
| 7,393,954 | Process for the production of pentostatin aglycone and pentostatin | July 1, 2008 |
| 6,596,858 | Process for the production of 2-halo-6-aminopurine derivatives | July 22, 2003 |
| 6,388,112 | Process for purification of solvents useful in the preparation of pharmaceutical compositions | May 14, 2002 |
| 6,252,061 | Process for the production of 2-halo-6-aminopurine derivatives | June 26, 2001 |
| 5,714,598 | Sulfated acid amides having anticoagulant properties | February 3, 1998 |
| 5,589,588 | Sulfated acid amides having anticoagulant properties | December 31, 1996 |
Patent Applications [US & PCT]
| Publication Number | Title | Publication Date |
| WO/2011/014793 | Process For Preparing Fondaparinux Sodium And Intermediates Useful In The Synthesis Thereof | February 3, 2011 |
| US20100081627 | Polymeric Nucleoside Prodrugs | April 1, 2010 |